Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | Inherited predispositions to multiple myeloma

Mehmet Samur • 10 Dec 2022
ASH 2022
Multiple Myeloma

Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, talks on ongoing research to identify inherited single nucleotide polymorphisms (SNPs) and genetic risk factors that contribute to the development of multiple myeloma, highlighting how this research is in its nascency. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Mehmet Samur

1:36
Improving the identification of patients with high-risk multiple myeloma
Mehmet Samur • 10 Dec 2022
2:37
Genomic factors impacting survival in patients with myeloma without known cytogenetic risk features
Mehmet Samur • 10 Dec 2022
3:00
Processes leading to the development of hyperdiploidy in multiple myeloma
Mehmet Samur • 10 Dec 2022
1:59
Investigating the mechanisms of initial & acquired resistance to BCMA CAR-T therapy in myeloma
Mehmet Samur • 10 Dec 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals